Subsequent over-expression of TIM-3 in glioblastoma cell lines led to an NFκB/interleukin-6 (IL-6)-dependent enhancement of proliferation, migration, and invasion in vitro, and significant tumor growth and reduced mouse survival in vivo [67]. The gene discussed is HAVCR2; the disease is glioblastoma.